108 related articles for article (PubMed ID: 37119607)
1. Extracellular alkaline pH enhances migratory behaviors of hepatocellular carcinoma cells as a caution against the indiscriminate application of alkalinizing drug therapy: In vitro microscopic studies.
Hanafy NAN
Acta Histochem; 2023 May; 125(4):152032. PubMed ID: 37119607
[TBL] [Abstract][Full Text] [Related]
2. Strong enhancement by IGF1-R antagonists of hepatocellular carcinoma cell migration inhibition by Sorafenib and/or vitamin K1.
D'Alessandro R; Refolo MG; Lippolis C; Carella N; Messa C; Cavallini A; Carr BI
Cell Oncol (Dordr); 2018 Jun; 41(3):283-296. PubMed ID: 29470830
[TBL] [Abstract][Full Text] [Related]
3. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
Huang D; Cao L; Zheng S
J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
[TBL] [Abstract][Full Text] [Related]
4. ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures.
Shi H; Xiao L; Duan W; He H; Ma L; Da M; Duan Y; Wang Q; Wu H; Song X; Hou Y
Micron; 2016 Jun; 85():26-33. PubMed ID: 27060670
[TBL] [Abstract][Full Text] [Related]
5. Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways.
Shi C; Cai Y; Li Y; Li Y; Hu N; Ma S; Hu S; Zhu P; Wang W; Zhou H
Redox Biol; 2018 Apr; 14():59-71. PubMed ID: 28869833
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
7. Twist expression promotes migration and invasion in hepatocellular carcinoma.
Matsuo N; Shiraha H; Fujikawa T; Takaoka N; Ueda N; Tanaka S; Nishina S; Nakanishi Y; Uemura M; Takaki A; Nakamura S; Kobayashi Y; Nouso K; Yagi T; Yamamoto K
BMC Cancer; 2009 Jul; 9():240. PubMed ID: 19615090
[TBL] [Abstract][Full Text] [Related]
8. F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration.
Wang N; Feng Y; Lau EP; Tsang C; Ching Y; Man K; Tong Y; Nagamatsu T; Su W; Tsao S
Integr Cancer Ther; 2010 Dec; 9(4):354-64. PubMed ID: 21106616
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stellate cells stimulate HCC cell migration via laminin-5 production.
Santamato A; Fransvea E; Dituri F; Caligiuri A; Quaranta M; Niimi T; Pinzani M; Antonaci S; Giannelli G
Clin Sci (Lond); 2011 Aug; 121(4):159-68. PubMed ID: 21413933
[TBL] [Abstract][Full Text] [Related]
10. [Migration and invasion of human hepatocellular carcinoma mediated by lung extracts].
Ji XN; Ye SL; Li Y; Tian B; Chen J; Liu YK; Tang ZY
Ai Zheng; 2004 Jan; 23(1):23-7. PubMed ID: 14720369
[TBL] [Abstract][Full Text] [Related]
11. BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.
Han P; Fu Y; Luo M; He J; Liu J; Liao J; Tian D; Yan W
Dig Dis Sci; 2014 May; 59(5):992-1000. PubMed ID: 24442236
[TBL] [Abstract][Full Text] [Related]
12. [The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Wu WZ; Zhou K; Liu KD
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):489-94. PubMed ID: 16867268
[TBL] [Abstract][Full Text] [Related]
13. BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB
Stem Cell Res Ther; 2019 Aug; 10(1):237. PubMed ID: 31387619
[TBL] [Abstract][Full Text] [Related]
14. Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.
Wong CC; Wong CM; Tung EK; Man K; Ng IO
Hepatology; 2009 May; 49(5):1583-94. PubMed ID: 19205033
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
[TBL] [Abstract][Full Text] [Related]
16. Identification of ACTG2 functions as a promoter gene in hepatocellular carcinoma cells migration and tumor metastasis.
Wu Y; Liu ZG; Shi MQ; Yu HZ; Jiang XY; Yang AH; Fu XS; Xu Y; Yang S; Ni H; Shen SJ; Li WD
Biochem Biophys Res Commun; 2017 Sep; 491(2):537-544. PubMed ID: 28385530
[TBL] [Abstract][Full Text] [Related]
17. SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
Zhang YL; Li Q; Yang XM; Fang F; Li J; Wang YH; Yang Q; Zhu L; Nie HZ; Zhang XL; Feng MX; Jiang SH; Tian GA; Hu LP; Lee HY; Lee SJ; Xia Q; Zhang ZG
Cancer Res; 2018 May; 78(9):2305-2317. PubMed ID: 29440144
[TBL] [Abstract][Full Text] [Related]
18. Grp78 promotes the invasion of hepatocellular carcinoma.
Su R; Li Z; Li H; Song H; Bao C; Wei J; Cheng L
BMC Cancer; 2010 Jan; 10():20. PubMed ID: 20082722
[TBL] [Abstract][Full Text] [Related]
19. Septin11 promotes hepatocellular carcinoma cell motility by activating RhoA to regulate cytoskeleton and cell adhesion.
Fu L; Wang X; Yang Y; Chen M; Kuerban A; Liu H; Dong Y; Cai Q; Ma M; Wu X
Cell Death Dis; 2023 Apr; 14(4):280. PubMed ID: 37080972
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial fission promotes cell migration by Ca
Sun X; Cao H; Zhan L; Yin C; Wang G; Liang P; Li J; Wang Z; Liu B; Huang Q; Xing J
Liver Int; 2018 Jul; 38(7):1263-1272. PubMed ID: 29210177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
